Home › Core › ISCC-IDs › 28C9EXqBa3WXC

View ISCC-ID

Core Data

28C9EXqBa3WXC
ISCC-ID - digital asset identifier
CCe28wnNsSukV-CTKTKSrvArAor-CDEWMGqkhtW7s-CRGchJQjcMZWH
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

characterizing markets for biopharmaceutical innovations do biologics differ from small molecules

Ledger Reference

coblo
Source Ledger/Blockchain
12409885
N-th ISCC Decleration on source ledger
64bea13a61126e41c3431e87d6caaea55a7fb338f5807a142c5fbc7e575afec8
Hash of block that includes the ISCC-DECLARATION
c23d516e03c41936f8bb83793f9b4050872a5d095985aa20a4f9ca8fd0e27045
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?", "@type": "ScholarlyArticle", "genre": "report", "author": [{"name": "Mark Trusheim", "@type": "Person"}, {"name": "Murray Aitken", "@type": "Person"}, {"name": "Ernst Berndt", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://dspace.mit.edu/bitstream/1721.1/62181/1/Bernt-2010-Characterizing%20Markets%20for%20Biopharmaceutical%20Innovations%20Do%20Biologics%20Differ%20from%20Small%20Molecules.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "National Bureau of Economic Research", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.3386/w16014", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCe28wnNsSukV-CTKTKSrvArAor-CDEWMGqkhtW7s-CRGchJQjcMZWH", "propertyID": "ISCC"}], "datePublished": "2010-05-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close